Neeraj Dhaun

University of Edinburgh
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (25)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background and Aims Patients with kidney failure have a higher risk of cardiovascular disease compared with the general population. Whilst temporal trends of myocardial infarction and stroke are declining in the general population, these have not been evaluated in patients with kidney failure. This study aimed to describe national trends in the incidence, treatment, and outcomes of myocardial infarction and stroke in patients with kidney failure (i.e. on dialysis or with a kidney transplant) over a 20-year period, stratified by age and sex. Methods In this retrospective national data linkage study, all patients with kidney failure in Scotland (UK) receiving kidney replacement therapy between January 1996 and December 2016 were linked to national hospitalization, prescribing, and death records. The primary outcomes were the incidence of myocardial infarction and stroke, and subsequent cardiovascular death. Generalized additive models were constructed to estimate age-standardized, sex-stratified incidence rates and trends in cardiovascular and all-cause death. Results Amongst 16 050 patients with kidney failure [52 (SD 15) years; 41.5% women], there were 1992 [66 (SD 12) years; 34.8% women] and 996 [65 (SD 13) years; 45.1% women] incident myocardial infarctions and strokes, respectively, between January 1996 and December 2016. During this period, the age-standardized incidence of myocardial infarction per 100 000 decreased in men {from 4376 [95% confidence interval (CI) 3998–4785] to 1835 (95% CI 1692–1988)} and women [from 3268 (95% CI 2982–3593) to 1369 (95% CI 1257–1491)]. Similarly, the age-standardized incidence of stroke per 100 000 also decreased in men [from 1978 (95% CI 1795–2175) to 799 (95% CI 729–875)] and women [from 2234 (95% CI 2031–2468) to 903 (95% CI 824–990)]. Compared with the general population, the incidence of myocardial infarction was four- to eight-fold higher in patients with kidney failure, whilst for stroke it was two- to four-fold higher. The use of evidence-based cardioprotective treatment increased over the study period, and the predicted probability of cardiovascular death within 1 year of myocardial infarction for a 66-year-old patient with kidney failure (mean age of the cohort) fell in men (76.6% to 38.6%) and women (76.8% to 38.8%), and also decreased in both sexes following stroke (men, from 63.5% to 41.4%; women, from 67.6% to 45.8%). Conclusions The incidence of myocardial infarction and stroke has halved in patients with kidney failure over the past 20 years but remains significantly higher than in the general population. Despite improvements in treatment and outcomes, the prognosis of these patients following myocardial infarction and stroke remains poor.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Kathryn Martin

Senior Lecturer

University of Aberdeen

UNITED KINGDOM
View details

Lorna Paul

Glasgow Caledonian University

UNITED KINGDOM
View details

María José Soler

Hospital Universitari Vall d'Hebron

SPAIN
View details

Peter Gallacher

SCREDS Clinical Lecturer in General Practice

University of Edinburgh

UNITED KINGDOM
View details

John Norrie

Professor and Director

University of Edinburgh

UNITED KINGDOM
View details

Matthew Bailey

Professor of Renal Physiology

University of Edinburgh

UNITED KINGDOM
View details

Graeme MacLennan

University of Aberdeen

UNITED KINGDOM
View details

Robert Hunter

Clinical Lecturer

University of Edinburgh

UNITED KINGDOM
View details

Nicholas Beare

Senior Lecturer

University of Liverpool

UNITED KINGDOM
View details

Amy Buck

Professor of RNA & Infection Biology

University of Edinburgh

UNITED KINGDOM
View details

Lorna Aucott

University of Aberdeen

UNITED KINGDOM
View details

Richard Emsley

King’s College London

UNITED KINGDOM
View details

Ruth Hogg

The Queen's University Belfast

UNITED KINGDOM
View details

David John Webb

Christison Professor of Therapeutics and Clinical Pharmacology

University of Edinburgh

UNITED KINGDOM
View details

Stuart Gray

Senior Lecturer in Exercise and Metabolic Health

University of Glasgow

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.